AAM Calls on FTC to Investigate PBM Business Practices
![](https://markupmadness.org/wp-content/uploads/2022/05/AAM-Calls-on-FTC-to-Investigate-PBM-Business-Practices.jpg)
Generic Manufacturers Ask the DOJ and the FTC to Investigate Market Abuses by Buying Groups
![](https://markupmadness.org/wp-content/uploads/2022/03/blog12.jpg)
Seniors Are Still Missing Out on Savings in Medicare Part D
![](https://markupmadness.org/wp-content/uploads/2022/03/blog04.jpg)
Generic Prices Are Falling, But Seniors Are Paying More for Generic Drugs. What’s Happening Here?
![](https://markupmadness.org/wp-content/uploads/2022/03/blog07.jpg)
2021 U.S. Generic and Biosimilar Medicines Savings Report
![](https://markupmadness.org/wp-content/uploads/2022/03/AAM-2021SR.jpg)
Sidelined: How Seniors Miss Out On Savings Available Through Generic Substitution
![](https://markupmadness.org/wp-content/uploads/2022/03/whitepaper-sidelined.jpg)
Access Denied: Why New Generics Are Not Reaching America’s Seniors
![](https://markupmadness.org/wp-content/uploads/2022/03/accessdenied.jpg)
AAM Securing Sustainable Markets
![](https://markupmadness.org/wp-content/uploads/2022/03/AAM-SustainableMarkets-Dev-11-1-791x1024.jpg)
Abuse of the patent system is keeping drug prices high for patients
![](https://markupmadness.org/wp-content/uploads/2022/03/blog06.jpg)
The Medicaid Generics Penalty: A Primer
![](https://markupmadness.org/wp-content/uploads/2022/03/blog05.jpg)